InMed Pharmaceuticals

About:

InMed Pharmaceuticals is a clinical-stage company developing cannabinoid-based pharmaceutical drug candidates.

Website: https://www.inmedpharma.com

Top Investors: National Research Council of Canada Industrial Research Assistance Program

Description:

InMed Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of cannabinoid-based medications, initially focused on the therapeutic benefits of cannabinol ("CBN") in diseases with high unmet medical needs. The Company is dedicated to delivering new therapeutic alternatives to patients that may benefit from cannabinoid-based medicines. InMed Pharmaceuticals was established in 1981 in Vancouver, Columbia by Chris Bogart.

Total Funding Amount:

$69.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Vancouver, British Columbia, Canada

Founded Date:

1981-01-01

Founders:

Chris Bogart

Number of Employees:

11-50

Last Funding Date:

2022-11-18

IPO Status:

Public

Industries: